BEAM — BEAM THERAPEUTICS INC

Ownership history in Man Group plc · 8 quarters on record

This page tracks every 13F SEC filing in which Man Group plc reported a position in BEAM THERAPEUTICS INC (BEAM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

0.02% (2022 Q2)

Avg. % of fund

0.0%

First filed

2020 Q4

Last filed

2025 Q3

Quarters held

8

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q3	ADDED	71,720	+58,603	+446.8%	0.00%	$1.7M	$24.27
2023 Q3	REDUCED	13,117	-52,827	-80.1%	0.00%	$315K	$24.05
2023 Q2	ADDED	65,944	+55,980	+561.8%	0.01%	$2.1M	$31.93
2023 Q1	REDUCED	9,964	-83,345	-89.3%	0.00%	$305K	$30.62

% of Fund (quarterly) BEAM price (monthly, adj. close)

Other funds also holding BEAM

As of 2025 Q4 — sorted by position size

MWG Caph Ltd 48.53% ARCH Venture Management, LLC 3Y 7Y 19.31% Kynam Capital Management, LP 3Y 4.32% Elmind Capital, LP 3.9% Casdin Capital, LLC 3Y 7Y 2.75% Redmile Group, LLC 3Y 7Y 2.62% ARK Investment Management LLC 3Y 7Y 2.29% Kynam Capital Management, LP 3Y 1.66% Amova Asset Management Americas, Inc. 3Y 7Y 1.41% FARALLON CAPITAL MANAGEMENT LLC 3Y 7Y 1.32%

← Back to Man Group plc Holdings